A case of endophthalmitis caused by Williamsia muralis is described. The infection occurred following a procedure known as intravitreal triamcinolone acetonide injection for the treatment of diabetic maculopathy. This is the first report of W. muralis as a causative agent of endophthalmitis.
KämpferP.,
SteiofM.,
DottW.1991; Microbiological characterization of a fuel-oil contaminated site including numerical identification of heterotrophic water and soil bacteria. Microb Ecol 21:227–251[CrossRef]
KämpferP.,
AnderssonM. A.,
KroppenstedtR. M.,
Salkinoja-SalonenM.1999; Williamsia muralis gen. nov., sp. nov. isolated from the indoor environment of a children's day care centre. Int J Syst Bacteriol 49:681–687[CrossRef]
KämpferP.,
BuczolitsS.,
AlbrechtA.,
BusseH.-J.,
StackebrandtE.2003; Towards a standardized format for the description of a novel species (of an established genus): Ochrobactrum gallinifaecis sp. nov. Int J Syst Evol Microbiol 53:893–896[CrossRef]
StachJ. E. M.,
MaldonadoL. A.,
WardA. C.,
BullA. T.,
GoodfellowM.2004; Williamsia maris sp. nov., a novel actinomycete isolated from the sea of Japan. Int J Syst Evol Microbiol 54:191–194[CrossRef]
YassinA. F.,
HupferH.2006; Williamsia deligens sp. nov., a novel species of the genus Williamsia isolated from human blood. Int J Syst Evol Microbiol 56:193–197[CrossRef]
ZiemkeF.,
HöfleM.,
LalucatJ.,
Rosselló-MoraR.1998; Reclassification of Shewanella putrefaciens Owen's genomic group II as Shewanella baltica sp. nov. Int J Syst Bacteriol 48:179–186[CrossRef]